1BENICHOU C, DANAN G, BENHAMOU JP,et al. Criteria of drug-induced liver disorders. Report of an international consensus meet-ing [J]. J Hepatol,1990,11 (2) :272.
2BEICHOU C, DANAN G, BENHAMOU JP, et al. Criteria of drug-induced liver disorders. Report of an international consensus meeting [ J ]. J Hepatol, 1990,112:272.
3Hussain Z, Kar P, Husain SA. Antituberculosis drug-induced hepatitis: risk factors, prevention and management. Indian J Exp Biol,2003,41 : 1226-1232.
4Onnerod LP, Horsfleld N. Frequency and type of reactions to antituberculosis drugs: observations in routine treatment. Tuber Lung Dis, 1996,77:37-42.
5Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology, 1997,26,664-669.
6Danan G, Benichou C, Flahault A. Score of suspected drug-induced acute liver disorders. Presentation of an evaluation sheet. Gastroenterol Clin Biol, 1993,17 ( 5 pt 2 ) : H22-H24.
7Iwasa M ,Zeniya M,Kumagi T,et al. Modified diagnostic criteria of drug-induced liver injury proposed by the intemational consensus meeting, Hepatogastroenteroloty,2005,52:869-874.
8Durand F, Jebrak G, Pessayre D, et al. Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Saf, 1996,15 : 394-405.
9Ungo JR, Jones D, Ashkin D, et al. Antituberculosis drug-inducted hepatotoxicity. The role of hepatitis C virus and the human immunodeficiency virus. AM J Respir Crit Care Med, 1998,157(6 Pt 1 ):1871-1876.
10Tost JR,Vidal R, Cayla J,et al. Severe hepatotoxicity due to anti- tuberculosis drugs in Spain. Int J Tuberc Lung Dis,2005,9:534- 540.
